Despite numerous studies suggesting that Maspin may influence tumor behavior and patient outcomes in breast, prostate, gastric, and colorectal cancers, there is incomplete data regarding its expression and prognostic implications in STS. Here, SERPINB5 is linked to colorectal cancer.